AI Drug Discovery Startups: Atomwise Focuses on AI-based Small Molecule Discovery

The Small Molecule Drug Discovery Market is estimated to grow at 9% CAGR from $74.08 billion in 2024 to reach $175.41 billion by 2034. San Francisco-based Atomwise is one player that is making use of its AI capabilities to make a mark in the industry.

Featured Videos

AI Drug Discovery Startups: Could Insilico Medicine Release the First Drug to be Discovered by AI?

The global artificial intelligence in drug discovery market is projected to grow at 22% CAGR from $1.7 billion in 2023 to reach $11.93 billion by 2033. The healthcare industry is increasingly adopting AI solutions to alleviate the significant financial burdens and potential setbacks that are associated with the drug discovery process. Hong Kong’s InSilico Medicine is one such leading player in the market.

AI Drug Discovery Stocks: Recursion Pharmaceuticals Has a Long Road Ahead

Among the various use-cases for AI, healthcare has been one of the interesting ones. Recursion Pharmaceuticals (NASDAQ: RXRX) is one such notable player in the industry that has successfully leveraged AI in drug discovery.

Exa Wants to be the Google for AI

The increased adoption of AI has led to a surge of new use cases across all industries. One such interesting use-case is being developed by San Francisco-based Exa which is trying build a search engine for AI.

Duolingo Empowers Lily with AI

According to a recent report, the global Online Language Learning Market is estimated to grow 13% over the next few years to reach $16.1 billion by 2032. Online language learning service provider Duolingo (Nasdaq: DUOL) recently announced their quarterly results that surpassed market expectations.

Cloud Stocks: MongoDB Focuses on AI Platform Development

MongoDB (NASDAQ: MDB) reported stellar third quarter results last week. However, sudden leadership changes and worries about a weak sequential growth sent the stock falling 8% in the after-hours session.

Cloud Stocks: Symbotic Leverages AI to Provide Warehousing-as-a-Service

The rise of AI in the recent past has exposed some interesting use-cases across industries. One such example is that of Wilmington, Mass.-based software and robotics maker Symbotic (NASDAQ: SYM), who has successfully leveraged AI to build an offering of Warehouses-as-a-Service.

Cloud Stocks: Veeva Accelerates AI Initiatives

Veeva’s (NYSE: VEEV) recently announced quarterly results continue to impress the market. Veeva is adding AI capabilities to several of its offerings as it continues to successfully migrate its customers over to Vault CRM.

Cloud Stocks: Salesforce Cashes in on the Agentic AI Market

Salesforce (NYSE: CRM) recently announced its third quarter results that beat the market expectations and sent the stock climbing 12%. According to a recent report, agentic AI is expected to reach $31 billion in 2024, with a potential to grow at 32% CAGR. Salesforce’s Agentforce offering is already reaping benefits from this growth.

Cloud Stocks: Analysis of Workday’s Evisort Acquisition

Enterprise services provider Workday (NASDAQ: WDAY) recently announced its third quarter results that surpassed market expectations. However, the weaker outlook for the final quarter sent the stock tumbling 11% in the after-hours trading session.